-+ 0.00%
-+ 0.00%
-+ 0.00%

The Zhitong Finance App learned that LLY.US (LLY.US) has signed a license and development agreement with Camurus. The two sides will jointly develop long-lasting insulin-promoting drugs for the treatment of obesity, diabetes, and other metabolic diseases based on Camurus' FluidCrystal technology.

Zhitongcaijing·06/04/2025 03:17:03
Listen to the news
The Zhitong Finance App learned that LLY.US (LLY.US) has signed a license and development agreement with Camurus. The two sides will jointly develop long-lasting insulin-promoting drugs for the treatment of obesity, diabetes, and other metabolic diseases based on Camurus' FluidCrystal technology.